Craig-Hallum Reiterates Buy Rating for PepGen Inc.
PepGen Inc. received a reaffirmed buy rating from Craig-Hallum with an $11 price target, a 501.09% upside from the current price.
Key Points
- Craig-Hallum analyst Adam Vogel reiterated a buy rating for PepGen Inc. (PEPG) with a price target of $11.
- Craig-Hallum's $11 price target implies 501.09% upside from PepGen Inc.'s ($PEPG) current $1.83 share price.
- PepGen Inc. trades at $1.53 on NasdaqGS with a market cap of about $110 million and a 52-week range from $1.01 to $7.80.
- Insider transactions include CEO James McArthur buying 187,688 shares on March 1, 2026, while Craig-Hallum maintains a strong buy consensus.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Craig-Hallum has reiterated its buy rating for PepGen Inc. (NasdaqGS: PEPG) with a price target of $11, according to analyst Adam Vogel on June 16, 2026. PepGen's stock is currently trading at $1.53.
Other Institutional Activity in PepGen Inc.
RA Capital Management, L.P. holds 20,064,545 shares of PepGen, valued at about $35.5 million, with no change in its holdings. Commodore Capital LP increased its stake by 1,075,000 shares, bringing its total to 4,475,000 shares worth approximately $7.9 million. Laurion Capital Management LP grew its holdings by 698,722 shares to a total of 2,750,855 shares, valued at around $4.9 million. Meanwhile, Millennium Management LLC made a significant addition of 1,881,200 shares, totaling 2,079,143 shares valued at roughly $3.7 million.
PepGen Inc. Stock Down 40.6%
Shares of PepGen Inc. (NasdaqGS: PEPG) are trading near $1.53. The company has a market capitalization of approximately $110 million. It is not currently profitable, which means it has no meaningful P/E ratio. The stock's 52-week range spans from $1.01 to $7.80, with a 50-day moving average of $1.59 and a 200-day moving average of $4.05. PepGen maintains a strong current ratio of 14.98 and a quick ratio of 14.76, with a debt-to-equity ratio of 12.36.
$PEPG price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at PepGen Inc.
Recent insider transactions at PepGen include CEO James McArthur purchasing 187,688 shares on March 1, 2026. Chief Technical Officer Kasra Kasraian also acquired 135,000 shares on the same day. In contrast, several insiders, including Chief Financial Officer Noel Donnelly and CEO James McArthur, sold shares on March 4, 2026, at an average price of $6.23.
Analysts Set New Price Targets
On June 16, 2026, Craig-Hallum reiterated its buy rating for PepGen with an $11 price target. Previously, on May 13, 2026, Wedbush maintained a buy rating with a $4 target. Oppenheimer initiated coverage with a buy rating and a $15 target on February 25, 2026. The consensus among analysts is a strong buy, with an average target price of $10.14 based on seven opinions.
About PepGen Inc.
PepGen Inc. is a biotechnology company based in Boston, Massachusetts. It focuses on developing oligonucleotide therapeutics for severe neuromuscular and neurologic diseases. The company is advancing its lead product candidates, PGN-EDODM1 and FREEDOM2-DM1, through Phase 2 clinical trials for myotonic dystrophy type 1. Founded in 2018, PepGen is led by CEO Dr. James G. McArthur and employs 56 people.
Bottom Line
Craig-Hallum's reiterated buy rating with an $11 target underscores continued confidence in PepGen's potential. Investors closely watch these analyst ratings as they provide insights into market sentiment. It's important to remember that these ratings and targets are based on past data and may not reflect current market conditions.
Get PepGen Inc. alerts
New 13F filings, insider trades, and analyst moves on $PEPG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.